Liver Damage Lawsuit News and Information
Hydroxycut Lawsuits
Popular over-the-counter dietary supplements marketed as Hydroxycut have been linked to serious side effects like liver damage, liver failure and death. A Hydroxycut recall was issued on May 1, 2009, and potential lawsuits are being pursued for individuals who have experienced problems caused by the weight-loss products.
All Articles Tagged With: "Liver Damage"
HIV Drug Videx Side Effects Linked to Liver Problems: FDA
Federal regulators are warning that the Bristol-Myers Squib HIV drug Videx appears to be linked to rare liver problems, known as non-cirrotic portal hypertension, which could be fatal for some users.
Doctors Warned to Watch Dosage of Velcade in Liver Patients
The multiple myeloma drug Velcade has been found to increase the risk of liver toxicity and liver damage in patients suffering from moderate to severe liver problems, resulting in a warning to doctors this month that such patients should be started on low doses of the drug.
M-Drol Lawsuit Filed Over Liver Damage From Dietary Supplement
Two men are suing the makers of M-Drol and P-Plex, two muscle-building dietary supplements sold online, which they allege caused them to suffer liver damage.
New FDA Program Targets Medication Misuse, Accidental Overdoses
The FDA has launched a new program called the “Safe Use Initiative,” which agency officials hope will cut down on medication injuries that could have been prevented.
Hydroxycut Litigation Over Recalled Supplement Consolidated in MDL
The U.S. Judicial Panel on Multidistrict Litigation has ordered that the federal Hydroxycut litigation, involving claims for liver damage and other health problems allegedly caused by the recalled dietary supplement, will be consolidated and centralized for pretrial proceedings in the U.S. District Court for the Southern District of California.
Hydroxycut Lawsuit Consolidation Request Scheduled for MDL Panel Hearing
A hearing before the U.S. Judicial Panel on Multidistrict Litigation is scheduled for later this month to determine whether all federal Hydroxycut lawsuits filed in various courts throughout the country should be centralized and consolidated before one judge for pretrial litigation as part of an MDL, or Multidistrict Litigation.
Alli Liver Damage Risk Refuted by GlaxoSmithKline
GlaxoSmithKline PLC has released a statement in support of their orlistat-based weight-loss drug Alli, following the FDA’s announcement Monday that they are investigating reports of liver damage that may be linked to Alli and Xenical.
Avandia Liver Failure Side Effects Renew Calls for Recall
New research highlights the potential risk of liver failure from Avandia, renewing calls from the consumer advocacy group Public Citizen for an Avandia recall to be issued by the FDA.
Concentrated Acetaminophen Drop Recall: Possible Dosing Errors
More than 5,600 bottles of concentrated acetaminophen drops for infants have been recalled due to risk of overdose, liver injury or death from dosing errors.
Percocet and Vicodin Recall Urged by FDA Panel Evaluating Acetaminophen
An FDA advisory panel that was convened to review ways to reduce the risk of liver damage and death from acetaminophen, has recommended that a ban be issued on the use of popular medications like Vicondin and Percocet, which combine acetaminophen with other painkillers.
Contact a Lawyer
Submit information about your potential case to be reviewed by an attorney.
